Graham P. Lidgard
Net Worth

Last updated:

What is Graham P. Lidgard net worth?

The estimated net worth of Mr. Graham P. Lidgard is at least $56,858,872 as of 11 Mar 2021. He owns shares worth $1,780,612 as insider, has earned $43,138,500 from insider trading and has received compensation worth at least $11,939,760 in Exact Sciences Corporation.

What is the salary of Graham P. Lidgard?

Mr. Graham P. Lidgard salary is $852,840 per year as Emeritus Chief Science Officer in Exact Sciences Corporation.

How old is Graham P. Lidgard?

Mr. Graham P. Lidgard is 76 years old, born in 1949.

What stocks does Graham P. Lidgard currently own?

As insider, Mr. Graham P. Lidgard owns shares in one company:

Company Title Shares Price per share Total value
Exact Sciences Corporation (EXAS) Emeritus Chief Science Officer 38,367 $46.41 $1,780,612

What does Exact Sciences Corporation do?

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

EXAS logo
EXAS
Exact Sciences Corporation
$46.41

Graham P. Lidgard insider trading

Exact Sciences Corporation

Mr. Graham P. Lidgard has made 46 insider trades between 2011-2021, according to the Form 4 filled with the SEC. Most recently he sold 43,241 units of EXAS stock worth $5,621,330 on 11 Mar 2021.

The largest trade he's ever made was exercising 311,112 units of EXAS stock on 11 Nov 2016. As of 11 Mar 2021 he still owns at least 38,367 units of EXAS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 43,241 $130 $5,621,330
Option
Common Stock 43,241 $33.03 $1,428,034
Option
Common Stock 43,241 $22.19 $959,302
Option
Stock Option (right to buy) 43,241 $22.19 $959,302
Option
Stock Option (right to buy) 4,612 N/A N/A
Option
Common Stock 4,612 N/A N/A
Sale
Common Stock 11,735 N/A N/A
Sale
Common Stock 2,524 N/A N/A
Sale
Common Stock 1,603 $137.44 $220,316
Option
Restricted Stock Units 5,025 N/A N/A
Option
Common Stock 5,025 N/A N/A
Option
Restricted Stock Units 3,263 N/A N/A
Option
Common Stock 3,263 N/A N/A
Sale
Common Stock 5,842 $136.3 $796,265
Option
Restricted Stock Units 11,575 N/A N/A
Option
Common Stock 11,575 N/A N/A
Sale
Common Stock 2,131 N/A N/A
Option
Restricted Stock Units 3,972 N/A N/A
Option
Common Stock 3,972 N/A N/A
Sale
Common Stock 698 $75.01 $52,357
Sale
Common Stock 37,613 $75.01 $2,821,276
Sale
Common Stock 57,517 $70.88 $4,076,747
Sale
Common Stock 22,156 $75.35 $1,669,499
Sale
Common Stock 58,000 $69.26 $4,017,254
Option
Stock Option (right to buy) 7,163 $13.96 $99,995
Option
Common Stock 7,163 $13.96 $99,995
Sale
Common Stock 4,464 $53.21 $237,529
Sale
Common Stock 3,961 $52.19 $206,740
Option
Restricted Stock Units 8,425 N/A N/A
Option
Stock Option (right to buy) 6,125 $23.38 $143,203
Sale
Common Stock 6,125 $23.38 $143,203
Option
Common Stock 14,550 $11.69 $170,090
Sale
Common Stock 4,859 N/A N/A
Sale
Common Stock 16,688 $43.77 $730,501
Option
Stock Option (right to buy) 18,337 $28.07 $514,793
Option
Common Stock 27,237 $18.72 $509,768
Option
Restricted Stock Units 8,900 N/A N/A
Sale
Common Stock 7,178 $42.34 $303,902
Option
Common Stock 8,250 N/A N/A
Option
Restricted Stock Units 8,250 N/A N/A
Option
Restricted Stock Units 11,575 $21.68 $250,946
Option
Stock Option (right to buy) 20,250 $21.68 $439,020
Option
Common Stock 31,825 $21.68 $689,966
Sale
Common Stock 20,250 $39.9 $808,056
Sale
Common Stock 45,770 $58.31 $2,668,940
Sale
Common Stock 45,775 $53.62 $2,454,593
Option
Common Stock 35,250 $13.96 $492,090
Sale
Common Stock 81,025 $47.16 $3,820,734
Option
Stock Option (right to buy) 35,250 $13.96 $492,090
Option
Stock Option (right to buy) 33,075 $9.07 $299,990
Option
Common Stock 42,317 $9.95 $420,843
Option
Common Stock 75,683 $12.24 $926,587
Option
Stock Option (right to buy) 75,683 $12.24 $926,587
Sale
Common Stock 75,683 $41.08 $3,108,679
Sale
Common Stock 45,775 $41.49 $1,899,205
Sale
Common Stock 2,945 $21.16 $62,316
Option
Restricted Stock Units 8,425 N/A N/A
Option
Common Stock 8,425 N/A N/A
Sale
Common Stock 6,001 $21.48 $128,901
Option
Restricted Stock Units 8,900 N/A N/A
Option
Common Stock 8,900 N/A N/A
Option
Restricted Stock Units 8,250 N/A N/A
Sale
Common Stock 2,667 $21.57 $57,527
Option
Common Stock 8,250 N/A N/A
Option
Restricted Stock Units 7,225 N/A N/A
Option
Common Stock 7,225 N/A N/A
Option
Stock Option (right to buy) 63,888 $2.88 $183,997
Option
Common Stock 63,888 $2.88 $183,997
Sale
Common Stock 143,056 $17.36 $2,483,452
Sale
Common Stock 143,056 $17.36 $2,483,452
Sale
Common Stock 25,000 $17.68 $442,000
Option
Stock Option (right to buy) 311,112 $2.88 $896,003
Option
Common Stock 311,112 $2.88 $896,003
Sale
Common Stock 7,383 $14.82 $109,416
Option
Common Stock 25,000 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Sale
Common Stock 3,041 $6.05 $18,398
Option
Common Stock 8,425 N/A N/A
Option
Restricted Stock Units 8,425 N/A N/A
Sale
Common Stock 2,997 $5.52 $16,543
Option
Restricted Stock Units 8,250 N/A N/A
Option
Common Stock 8,250 N/A N/A
Sale
Common Stock 2,411 $6.39 $15,406
Option
Common Stock 7,225 N/A N/A
Option
Restricted Stock Units 7,225 N/A N/A
Sale
Common Stock 3,463 $8.72 $30,197
Option
Common Stock 6,566 N/A N/A
Option
Restricted Stock Units 6,566 N/A N/A
Sale
Common Stock 12,579 $24.04 $302,399
Option
Common Stock 25,000 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Sale
Common Stock 3,938 $23.44 $92,307
Sale
Common Stock 4,037 $22.9 $92,447
Option
Restricted Stock Units 8,250 N/A N/A
Option
Common Stock 8,250 N/A N/A
Option
Restricted Stock Units 7,225 N/A N/A
Option
Common Stock 7,225 N/A N/A
Sale
Common Stock 3,363 $26.72 $89,859
Option
Common Stock 6,567 N/A N/A
Option
Restricted Stock Units 6,567 N/A N/A
Sale
Common Stock 8,015 $24.68 $197,810
Option
Common Stock 125,000 $2.88 $360,000
Option
Stock Option (right to buy) 125,000 $2.88 $360,000
Sale
Common Stock 50,000 $2.88 $144,000
Option
Common Stock 50,000 $2.88 $144,000
Option
Stock Option (right to buy) 50,000 $2.88 $144,000
Sale
Common Stock 50,000 $2.88 $144,000
Option
Common Stock 50,000 $2.88 $144,000
Sale
Common Stock 50,000 $2.88 $144,000
Option
Stock Option (right to buy) 50,000 $2.88 $144,000
Sale
Common Stock 11,081 $15.99 $177,185
Option
Common Stock 25,000 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Sale
Common Stock 3,160 $14.07 $44,461
Option
Common Stock 7,225 N/A N/A
Sale
Common Stock 10,288 $11.96 $123,044
Option
Restricted Stock Units 23,234 N/A N/A
Option
Common Stock 23,234 N/A N/A
Option
Restricted Stock Units 23,234 N/A N/A
Sale
Common Stock 7,430 $11.07 $82,250
Option
Restricted Stock Units 16,667 N/A N/A
Option
Common Stock 16,667 N/A N/A
Option
Restricted Stock Units 16,667 N/A N/A
Option
Common Stock 16,667 N/A N/A

Exact Sciences key executives

Exact Sciences Corporation executives and other stock owners filed with the SEC:

  • Mr. D. Scott Coward (60) Chief Admin. Officer, Executive Vice President, Gen. Counsel & Sec.
  • Mr. Graham P. Lidgard (76) Emeritus Chief Science Officer
  • Mr. Jake Orville (51) Gen. Mang. of Pipeline
  • Mr. Jeffrey T. Elliott CFA (47) Executive Vice President, Chief Financial Officer & Chief Operating Officer
  • Mr. Kevin T. Conroy (59) Chairman, Pres & Chief Executive Officer